Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 49.33
-3.14 %
$ 9.13 B
Market Cap
-42.53
P/E
Price Target
Average
57.34%
Revenue Forecast
Estimate
11.42%
EBIT
Estimate
--56.71%
Net Income
Estimate
26.58%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exact Sciences Corporation
Wall Street analysts predict an average 1-year price target for EXAS of $77.6 , with forecasts ranging from a low of $65 to a high of $95 .
EXAS Lowest Price Target
Wall Street Target
65 USD
31.77%
EXAS Average Price Target
Wall Street Target
77.6 USD
57.34%
EXAS Highest Price Target
Wall Street Target
95 USD
92.58%
REVENUE FORECAST
Revenue Forecast Chart EXAS
EBIT FORECAST
EBIT Forecast Chart EXAS
NET INCOME FORECAST
Net Income Chart EXAS